Defining Aggressive Prostate Cancer Using a 12-Gene Model1
Under a Creative Commons license
open access
Keywords
Metastasis
cancer
proteomics
prostate cancer
bioinformatics
Abbreviations
PSA
prostate-specific antigen
AMACR
alpha-methylacyl COA racemase
FAS
fatty acid synthase
EZH2
enhancer of Zeste 2
ZAG
zinc alpha-2-glycoprotein
XIAP
X-linked inhibitor of apoptosis
TPD52
tumor protein D 52
KLF6
Kruppel-like factor 6
MTA1
metastasis-associated gene 1
Cited by (0)
- 1
This work was supported by SPORE National Cancer Institute (NCI) grants P50CA90381 (M.A.R.), P50CA69568(M.A.R. and A.M.C.), CA 97063(A.M.C. and M.A.R.), and R01AG21404 (M.A.R.), American Cancer Society grant RSG-02-179-MGO (A.M.C. and M.A.R.), Department of Defense (PC051081 to A.M.C. and S.V.), Early Detection Research Network (U01 CA111275-01 to A.M.C. and M.A.R.), NIH Prostate Specialized Program of Research Excellence(SPORE) (P50CA69568 to A.M.C.), and the UM Cancer Center Support Grant (5P30 CA46592). A.M.C. is a Pew Biomedical Scholar.
- 2
Tarek A. Bismar and Francesca Demichelis contributed equally to this work.
- 3
Drs. Chinnaiyan and Rubin share cosenior authorship.
Copyright © 2006 Neoplasia Press, Inc. Published by Elsevier Inc.